Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market definition
2.2. Market segmentation
3. Home Healthcare Market Insights
3.1. Home Healthcare - Industry snapshot
3.1.1. Leading Companies
3.1.2. Key Companies to Watch
3.2. Home Healthcare - Ecosystem analysis
3.2.1. Market overview
3.2.2. Commercial Landscape
3.3. Home Healthcare Market Dynamics
3.3.1. Home Healthcare - Market Forces
3.3.1.1. Home Healthcare Market Driver Analysis
3.3.1.2. Home Healthcare Market Restraint/Challenges analysis
3.3.1.3. Home Healthcare Market Opportunity Analysis
3.4. Industry analysis - Porter's five forces
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Home Healthcare Market PEST Analysis
3.6. Home Healthcare Market Value Chain Analysis
3.7. Home Healthcare Industry Trends
3.8. Competitive Ranking Analysis
4. Home Healthcare Market Size and Forecast, 2017-2025 by Component Types
4.1. Key Findings
4.2. Equipment
4.2.1. Mobility Assist
4.2.2. Therapeutics
4.2.3. Diagnostics
4.3. Service
4.3.1. Infusion Therapy Service
4.3.2. Telemetry
4.3.3. Respiratory Therapy Service
4.3.4. Rehabilitation
4.3.5. Unskilled Home Care
5. Home Healthcare Market Size and Forecast, 2017-2025 by Region
5.1. Key Findings
5.2. North America
5.2.1. U.S.
5.2.2. Canada
5.3. Europe
5.3.1. UK
5.3.2. Germany
5.3.3. France
5.3.4. Italy
5.3.5. Spain
5.3.6. Belgium
5.3.7. Russia
5.3.8. Netherlands
5.3.9. Rest of Europe
5.4. Asia-Pacific
5.4.1. China
5.4.2. Japan
5.4.3. India
5.4.4. Singapore
5.4.5. Malaysia
5.4.6. Indonesia
5.4.7. Thailand
5.4.8. Philippines
5.4.9. Australia
5.4.10. South Korea
5.4.11. Rest of Asia-Pacific
5.5. Latin America
5.5.1. Brazil
5.5.2. Mexico
5.5.3. Argentina
5.5.4. Rest of LATAM
5.6. Middle East & Africa
5.6.1. South Africa
5.6.2. UAE
5.6.3. Saudi Arabia
5.6.4. Rest of MEA
6. Company Profiles
6.1. GE Healthcare
6.1.1. Overview
6.1.2. Financials
6.1.3. Products/Offerings
6.1.4. Recent Developments
6.2. Bayer AG
6.2.1. Overview
6.2.2. Financials
6.2.3. Products/Offerings
6.2.4. Recent Developments
6.3. McKesson Corporation
6.3.1. Overview
6.3.2. Financials
6.3.3. Products/Offerings
6.3.4. Recent Developments
6.4. Roche Holding AG
6.4.1. Overview
6.4.2. Financials
6.4.3. Products/Offerings
6.4.4. Recent Developments
6.5. Linde Corporation
6.5.1. Overview
6.5.2. Financials
6.5.3. Products/Offerings
6.5.4. Recent Developments
6.6. Almost Family
6.6.1. Overview
6.6.2. Financials
6.6.3. Products/Offerings
6.6.4. Recent Developments
6.7. Amedisys
6.7.1. Overview
6.7.2. Financials
6.7.3. Products/Offerings
6.7.4. Recent Developments
6.8. Abbott Laboratories
6.8.1. Overview
6.8.2. Financials
6.8.3. Products/Offerings
6.8.4. Recent Developments
6.9. BAYADA Home Health Care
6.9.1. Overview
6.9.2. Financials
6.9.3. Products/Offerings
6.9.4. Recent Developments
6.10. Omron Healthcare
6.10.1. Overview
6.10.2. Financials
6.10.3. Products/Offerings
6.10.4. Recent Developments
6.11. Philips Healthcare
6.11.1. Overview
6.11.2. Financials
6.11.3. Products/Offerings
6.11.4. Recent Developments
6.12. A&D Company
6.12.1. Overview
6.12.2. Financials
6.12.3. Products/Offerings
6.12.4. Recent Developments
6.13. Kindred Healthcare
6.13.1. Overview
6.13.2. Financials
6.13.3. Products/Offerings
6.13.4. Recent Developments
6.14. LHC Group
6.14.1. Overview
6.14.2. Financials
6.14.3. Products/Offerings
6.14.4. Recent Developments
6.15. Fresenius
6.15.1. Overview
6.15.2. Financials
6.15.3. Products/Offerings
6.15.4. Recent Developments
6.16. Portea Medical
6.16.1. Overview
6.16.2. Financials
6.16.3. Products/Offerings
6.16.4. Recent Developments
6.17. Kinnser Software
6.17.1. Overview
6.17.2. Financials
6.17.3. Products/Offerings
6.17.4. Recent Developments